In just a few short weeks of #NationalDentalHygieneMonth, Oral Biolife is excited to have already announced such a promising breakthrough for the oral health industry. In reference to our recent large animal data discovery, our President Stella Vnook shares that, “At OBL our mission has always been to find a way to provide patients with access to non-invasive dental care. We are pleased with these promising results and are excited to continue our research to further establish the safety and efficacy of the Ambrilux Dental Gel.” Learn more about how OBL is pioneering a new path for oral healthcare in their latest release. Stella K. Vnook Bill Breitenbach Doug Nissinoff Kenneth Kilgore Dr. Ronaldo Santana DMD Dr. Shervin Molayem Kafka Media Group #oralhealth #nationaldentalhygienemonth #PD #dentalhealth #oralhealth #NationalDentalHygieneMonth #periodontalcare #dentalhealth https://lnkd.in/ezqhTnwD
关于我们
Oral Biolife is an innovative biotech company utilizing Piezo materials to develop a groundbreaking product, Ambrilux Dental Gel for the treatment of periodontal disease. OralBiolife's In-vivo studies have demonstrated bone regeneration measuring the distance between the bone line and a tooth reference. Calculated as a ratio before/after treatment. The results are astounding! After one month of therapy, Ambrilux Dental Gel showed a significant reduction in the exposed dental roots compared to the clinical standard. Our In-vivo data, demonstrates that Ambrilux Dental Gel is a superior treatment for periodontitis because of its unique regenerative bone properties. Since Ambrilux Dental Gel catalyzes bone regeneration, it has a significant medical and commercial advantage over existing non-surgical treatments. Oral Biolife has developed a Platform with this Technology: The bone-regenerating technology may be applied to many applications that require a sterile, high-quality seal with bone, including dental and orthopedic implants. The remineralization activity may also be applied to dental sealants and composite restorations.
- 网站
-
www.oralbiolife.com
Oral Biolife Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 类型
- 私人持股
- 创立
- 2022
- 领域
- Dental 、Periodontal Disease、Animal Health和Bone Reneration
Oral Biolife Inc.员工
-
Stella K. Vnook
Chief Executive Officer | Founder & President Biopharma Companies | Board Chair | Executive Advisor | Mentor | Fundraising | Licensing | M&A |…
-
Dr. Shervin Molayem
Periodontist, Dental Tech Advisor & Innovator, Board Member, Angel Investor, Researcher, Dental AI
-
Slava Rom
Biomedical Scientist, Educator, Lab Director
-
Doug Nissinoff
Venture Capital | Investing in the intersection of healthcare & AI
动态
-
Dental Products Report is showcasing Oral Biolife's recent achievement in a large mammal proof-of-concept study. Read the full article below: #DentalInnovation #OralHealth #PeriodontalDisease #BoneRegeneration Stella K. Vnook Bill Breitenbach Kenneth Kilgore Doug Nissinoff Alfonso Alejo Kafka Media Group Dental Products Report
Oral Biolife Announces Potential Breakthrough Periodontal Disease Gel
dentalproductsreport.com
-
Check out the latest headlines on Oral BioLife’s innovative large animal data! #Periodontaldisease #Boneregeneration #OralHealth Stella K. Vnook Bill Breitenbach Doug Nissinoff Kenneth Kilgore Kafka Media Group
Oral Biolife Announces Large Animal Data Breakthrough in Periodontal Disease
https://pulsexpertech.com
-
Oral Biolife (OBL) is excited to announce that our proof-of-concept study for Ambrilux Dental Gel(TM), a groundbreaking dental treatment for both humans and companion animals, has demonstrated its ability to promote bone regeneration in the furcation areas of teeth in canines with induced periodontal disease (PD). At Oral Biolife, we are dedicated to pushing the boundaries of dental care innovation. These results for Ambrilux Dental Gel(TM) bring OBL one step closer to delivering a breakthrough solution for a non-invasive dental treatment for periodontal disease. Thank you to the entire OBL team who helped us achieve this milestone. Bill #periodontaldisease #boneregeneration #OralHealth #DentalInnovation Stella K. Vnook Bill Breitenbach Doug Nissinoff Kenneth Kilgore Dr. Shervin Molayem Alfonso Alejo J. Todd Abrams Bullpen https://lnkd.in/eErGkg4a
Oral Biolife Announces Large Animal Data Breakthrough in Periodontal Disease
einnews.com
-
Oral Biolife is proud to spotlight one of our core missions in honor of National Dental Hygiene Month. Practicing good dental hygiene not only reduces the risk of various diseases but also promotes better mental health and ensures long-lasting teeth and gum health. It's a crucial habit to prioritize, not just this month, but all year round. Discover more about OBL’s commitment to elevating the standards of dental and oral health care here: https://lnkd.in/erpqeHNX #Oralhealth #boneregeneration #PeriodontalDisease Stella K. Vnook Bill Breitenbach Doug Nissinoff Kenneth Kilgore Dr. Shervin Molayem J. Todd Abrams
Home | Oral Biolife
https://oralbiolife.com
-
Our Founder and President, Stella Vnook, was recently featured on The Biohub Podcast, a platform known for engaging conversations with top leaders in the Biotech and Pharma industries. In the episode, Stella opened up about her journey, from her upbringing to the challenges she's overcome as a woman in this field, as well as the innovative strategies and successes that define her work today. Without the knowledge and expertise that Stella has pioneered, Oral Biolife would not have the breakthrough treatments and research that have led us to the hopeful future we hold for oral health today. Listen to Stella’s insightful interview on The Biohub Podcast here! https://lnkd.in/eyQfnCXB Stella K. Vnook Bill Breitenbach Doug Nissinoff Kenneth Kilgore Bullpen #Oralhealth #DentalInnovation #Boneregeneration #Periodontaldisease
The BioHub - The Avetix Podcast - S2 Ep9 - Stella Vnook
https://www.youtube.com/
-
Thank you, Rama On Healthcare, for showcasing our President and Founder, Stella Vnook, in this insightful interview! In it, Stella discusses the transformative role of technology in healthcare and shares her journey as a leader in the industry. Don’t miss Stella’s Q&A interview—read it with the link below: RamaOnHealthcare Stella K. Vnook Bill Breitenbach Doug Nissinoff Kenneth Kilgore Kafka Media Group Katelyn Duffy Michelle Kafka #OralHealth #Innovation #DigitalHealthPlatforms
Q&A: Dr. Stella Vnook, President and Founder of Oral BioLife – RamaOnHealthcare
ramaonhealthcare.com
-
The Oral Biolife team is excited to announce a strategic partnership with a top-tier global leader in animal health. Together, we are developing a product to revolutionize the treatment of periodontal disease in companion animals. To learn more click the link below: Stella K. Vnook Bill Breitenbach Doug Nissinoff Kenneth Kilgore Christopher Graham Alfonso Alejo April Stanley, MS, MBA Bullpen Kafka Media Group Abby Cook Michelle Kafka #CompanionAnimalOralHealth #PeriodontalDisease #Innovation
Oral Biolife Inc. Announces Animal Health Partnership to Support Animal Oral Health
einnews.com
-
Our President and Founder, Stella Vnook, sat down with Authority Magazine to share how OBL’s technology is changing overall wellness. Stella gives insights into her career, future predictions, and Oral Biolife’s impact on healthcare. “At Oral BioLife, our focus lies in pioneering treatments for periodontal disease using advanced biotechnology.” - President of Oral Biolife, Stella Vnook. Interested in reading more? Click the link below! Stella K. Vnook Bill Breitenbach Doug Nissinoff Kenneth Kilgore Kafka Media Group Abby Cook Authority Magazine Alfonso Alejo
Health Tech: Dr Stella Vnook Of Likarda Biotech On How Their Technology Can Make An Important Impac
medium.com
-
In this recent interview with PharmExec, our very own President and Founder, Stella Vnook talks about all things periodontal treatment, including the science behind periodontal technology, our Ambrilux Dental Gel, and OBL’s mission to spread periodontal awareness. “Periodontal disease is a silent epidemic that is affecting millions. At Oral Biolife, we are eager to continue spreading awareness of this infectious disease and committed to advancing our efforts in finding a solution.” Bill Breitenbach, CEO of Oral Biolife. Want to learn more? Click the link below! Stella K. Vnook Bill Breitenbach Doug Nissinoff Abby Cook Kafka Media Group Kenneth Kilgore Michelle Kafka J. Todd Abrams Alfonso Alejo
The Future of Periodontal Treatment
pharmexec.com